These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of gamma-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene. Menendez JA; Vellon L; Colomer R; Lupu R J Natl Cancer Inst; 2005 Nov; 97(21):1611-5. PubMed ID: 16264182 [TBL] [Abstract][Full Text] [Related]
5. Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification. Menendez JA; Vellon L; Colomer R; Lupu R Ann Oncol; 2005 Mar; 16(3):359-71. PubMed ID: 15642702 [TBL] [Abstract][Full Text] [Related]
6. DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes. Menendez JA; Vellon L; Lupu R Int J Mol Med; 2006 Dec; 18(6):1081-7. PubMed ID: 17089011 [TBL] [Abstract][Full Text] [Related]
7. PEA3 cooperates with c-Jun in regulation of HER2/neu transcription. Matsui K; Sugimori K; Motomura H; Ejiri N; Tsukada K; Kitajima I Oncol Rep; 2006 Jul; 16(1):153-8. PubMed ID: 16786139 [TBL] [Abstract][Full Text] [Related]
8. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene. Menendez JA; Vellon L; Lupu R Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086 [TBL] [Abstract][Full Text] [Related]
9. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Benz CC; O'Hagan RC; Richter B; Scott GK; Chang CH; Xiong X; Chew K; Ljung BM; Edgerton S; Thor A; Hassell JA Oncogene; 1997 Sep; 15(13):1513-25. PubMed ID: 9380403 [TBL] [Abstract][Full Text] [Related]
10. SV40 T/t-common polypeptide specifically induces apoptosis in human cancer cells that overexpress HER2/neu. Wen CC; Cheng SA; Hsuen SP; Huang YL; Kuo ZK; Lee HF; Kuo CH; Du JL; Wang WB Cancer Res; 2006 Jun; 66(11):5847-57. PubMed ID: 16740724 [TBL] [Abstract][Full Text] [Related]
11. Expression of PEA3 and lack of correlation between PEA3 and HER-2/neu expression in breast cancer. Xia WY; Lien HC; Wang SC; Pan Y; Sahin A; Kuo YH; Chang KJ; Zhou X; Wang H; Yu Z; Hortobagyi G; Shi DR; Hung MC Breast Cancer Res Treat; 2006 Aug; 98(3):295-301. PubMed ID: 16752078 [TBL] [Abstract][Full Text] [Related]
12. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis. Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577 [TBL] [Abstract][Full Text] [Related]
13. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. Yu D; Wolf JK; Scanlon M; Price JE; Hung MC Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034 [TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of an Ets protein, PEA3, in breast cancer cell lines MDA-MB-361DYT2 and BT474M1. Yu Z; Xia W; Wang HY; Wang SC; Pan Y; Kwong KY; Hortobagyi GN; Hung MC Mol Carcinog; 2006 Sep; 45(9):667-75. PubMed ID: 16652376 [TBL] [Abstract][Full Text] [Related]
15. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells. Hsu MC; Chang HC; Hung WC Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096 [TBL] [Abstract][Full Text] [Related]
16. The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells. Pegram MD; Finn RS; Arzoo K; Beryt M; Pietras RJ; Slamon DJ Oncogene; 1997 Jul; 15(5):537-47. PubMed ID: 9247307 [TBL] [Abstract][Full Text] [Related]
17. The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer. Chang JY; Xia W; Shao R; Sorgi F; Hortobagyi GN; Huang L; Hung MC Oncogene; 1997 Feb; 14(5):561-8. PubMed ID: 9053854 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional repression of the neu protooncogene by estrogen stimulated estrogen receptor. Russell KS; Hung MC Cancer Res; 1992 Dec; 52(23):6624-9. PubMed ID: 1358436 [TBL] [Abstract][Full Text] [Related]
19. Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarrays. Menendez JA; Vazquez-Martin A; Oliveras-Ferraros C; Garcia-Villalba R; Carrasco-Pancorbo A; Fernandez-Gutierrez A; Segura-Carretero A Int J Mol Med; 2008 Oct; 22(4):433-9. PubMed ID: 18813848 [TBL] [Abstract][Full Text] [Related]
20. The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis. Xing X; Wang SC; Xia W; Zou Y; Shao R; Kwong KY; Yu Z; Zhang S; Miller S; Huang L; Hung MC Nat Med; 2000 Feb; 6(2):189-95. PubMed ID: 10655108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]